Diagnostics & Testing

AdipoGen Life Sciences is a private life science reagents manufacturer and global distributor specializing in innovative antibodies, proteins, ELISA kits, small molecules and diagnostic kits for inflammation, immune responses, cancer and metabolic disorders. With corporate headquarters in San Diego and operational headquarters in Switzerland, plus R&D and production labs in Epalinges, it serves academic and industrial R&D worldwide through a broad, niche portfolio and technical support.

Nucleai is a private precision medicine company focused on AI-driven spatial biomarkers and digital pathology, primarily in oncology and immunology. It partners with biopharma, diagnostics companies, and research institutions to apply multimodal AI and spatial biology for predictive biomarker discovery, patient stratification, and trial optimization. Its platform analyzes digital pathology slides and clinical data to produce actionable insights for drug development and diagnostic programs.

Informuta develops AI-powered diagnostics that forecast antibiotic resistance before it emerges. Founded in 2023 and headquartered in San Diego, the company uses whole-genome mutational signatures and biologically explainable AI to predict treatment-emergent resistance risk. Peer-reviewed validation in Nature Communications demonstrated 92-100% accuracy in Pseudomonas aeruginosa resistance forecasting.

ATCC (American Type Culture Collection) is a nonprofit global bioresource center and standards organization supplying authenticated cell lines, microorganisms, organoids, nucleic acids, and reference materials. It supports oncology, immunology, toxicology, molecular diagnostics, and bioproduction with advanced models, standards, and ‘omics-backed data to improve assay reliability and research reproducibility.

Agilent Technologies is a public laboratory technology company based in Santa Clara, California. It supplies instruments, software, consumables, and services for pharma, diagnostics, and life-science labs across chromatography, mass spectrometry, spectroscopy, sample prep, and related workflows.

Alpha Laboratories (AlphaLabs) is an Ontario-based diagnostics provider offering medical laboratory testing, diagnostic imaging, ECG and Holter monitoring, and specimen collection services, supported by patient and clinician portals. It also delivers raw material analysis, elemental analysis, and pharmaceutical product testing for manufacturers, operating state-of-the-art, accredited laboratories licensed by the Ontario Ministry of Health.

Ambry Genetics is a diagnostics company focused on hereditary cancer testing, rare-disease exome sequencing, and RNA-enhanced variant interpretation. It also offers the CARE Program for patient identification and testing workflow support, making it relevant to clinical diagnostics buyers and research teams.

Amprion is a private neurodiagnostics company built around its SAAmplify-αSYN CSF assay for detecting misfolded α-synuclein. It serves clinicians, researchers, and biopharma teams working on Parkinson’s disease, Lewy body dementia, and other synucleinopathies.

AnteoTech is an ASX-listed Australian diagnostics and advanced materials company headquartered in Brisbane. Its Life Sciences division provides patented AnteoBind™ metal-ion surface chemistry and bioconjugation solutions that enhance immunoassays and IVD performance, supported by ISO 9001:2015–certified quality systems.

Abcam is a Cambridge, UK–headquartered supplier of antibodies, proteins, assays, cell lines, lysates, and related reagents that support life science research, drug discovery, and diagnostic and therapeutic applications. Now part of Danaher, it serves global academic, biotech, and pharma customers with an extensive, validated catalog spanning oncology, neuroscience, infectious diseases, and metabolic disorders.

BioLegend is a San Diego–based developer and manufacturer of antibodies, recombinant proteins, kits, proteogenomics tools and custom reagents for biomedical and clinical research. It supports immunology, oncology, neuroscience, stem cell and proteogenomics workflows with ISO 13485:2016–compliant products, IVD and ASR reagents, and extensive technical resources, serving global pharma and biotech R&D teams.

Aptamer Group is a York, UK‑based public biotech company specialising in custom aptamer and Optimer® binder solutions for research, diagnostics, therapeutics and bioprocessing. Using its Optimer affinity platform, it delivers next‑generation synthetic binders that address limitations of antibodies, enabling high-specificity, stable reagents tailored to demanding life science applications.

Arima Genomics is a private cancer diagnostics company that uses Hi-C–based 3D genome sequencing to integrate DNA sequence and structure for oncology testing. Through its Aventa clinical tests, biopharma partnerships and translational science collaborations, Arima detects clinically relevant fusions, rearrangements and structural mechanisms in solid tumors and lymphomas to refine diagnosis and guide therapy selection.

Gyros Protein Technologies, a division of Mesa Labs, provides Gyrolab® nanoliter-scale immunoassay platforms and PurePep® peptide synthesizers and purification technologies to accelerate biotherapeutic, cell and gene therapy, and vaccine development. Its instruments, reagents, and services support regulated bioanalytical and peptide workflows from discovery through manufacturing. Headquartered in Uppsala, Sweden, the company serves pharma, biotech, CRO, and CMO laboratories worldwide.

Biosero is a lab automation specialist that powers more than 1,000 labs worldwide with its Green Button Go Scheduler and Orchestrator platform and integrated workcells. It connects instruments, software and teams into end‑to‑end workflows for diagnostics, therapeutics, genomics, cell biology, drug discovery and sample management, helping pharma and R&D buyers improve throughput, consistency and scientist productivity.

Biocrates is a metabolomics-focused life science supplier providing standardized, quantitative mass spectrometry-based kits, software, and services for metabolic phenotyping. Headquartered in Innsbruck, Austria, the company’s portfolio enables robust measurement of hundreds to over a thousand metabolites across many biochemical classes, supporting biomarker discovery, clinical, nutritional, and systems biology research. Its mission is to make metabolomics accessible and reproducible for pharma, biotech, and

Biodesix is a public U.S. diagnostic solutions company specializing in blood-based lung nodule risk assessment and lung cancer treatment guidance tests, alongside custom development services. Its Nodify Lung and IQLung testing strategies support personalized clinical decisions, while development services help biopharma and life sciences partners build and commercialize new diagnostics and therapeutics.

Biohit Oyj is a Finnish public biotech and diagnostics company focused on innovative gastrointestinal diagnostics and disease prevention. Headquartered in Helsinki with subsidiaries in Italy and the UK, Biohit offers test systems such as GastroPanel and rapid GI tests, alongside monoclonal antibodies for research and diagnostic industry use.

Logical Biological is a UK-based supplier of human biological raw materials founded in 2019. Headquartered at Discovery Park in Sandwich, Kent, the company provides serum, plasma, urine, saliva, swabs, PBMCs, and tissue specimens for IVD control manufacturing and diagnostic research. ISO 9001:2015 certified and Human Tissue Act licensed.

Biotech Fluidics is a specialist supplier of liquid degassing and fluidic components for high‑precision analytical and processing systems. From its Swedish headquarters and global sales and manufacturing sites, it supports OEMs and laboratories in life science, diagnostics, chromatography and semiconductor manufacturing with degassers, inline monitoring tools, separation devices and flow components.

Broken String Biosciences is a private genomics technology company based at the Wellcome Genome Campus in Cambridge, UK, focused on genome-wide DNA break analysis for gene editing. Its BreakMap platform, powered by the PCR-free INDUCE-seq® assay and integrated bioinformatics, enables in-cell, unbiased detection of on- and off-target DNA breaks to support safer, regulator-ready development of cell and gene therapies.

CENTOGENE is a German precision medicine and genetic diagnostics company focused on rare and complex diseases, reproductive health, and oncology. It offers whole genome and exome sequencing, multiomic solutions, NGS panels, and non-invasive prenatal testing, underpinned by a biodatabank of over 1 million individuals and more than 350 publications. CENTOGENE also partners with pharma to use multiomic and real-world data to accelerate drug discovery and development.

CARB-X is a Boston University–led global non-profit accelerator focused on early-stage antibacterial R&D, funding new antibiotics, preventatives and rapid diagnostics against drug‑resistant bacteria. It provides non‑dilutive funding plus scientific, regulatory and business support to advance innovative products from basic research toward first‑in‑human studies, with a portfolio described as the world’s most diverse early antibacterial pipeline.

Cleveland Diagnostics is a private oncology diagnostics company based in Cleveland, Ohio, focused on blood-based cancer tests built on its IsoClear™ protein structure platform. Its lead product, IsoPSA®, is an FDA‑approved assay for aiding detection of high‑grade prostate cancer and reducing unnecessary biopsies, supported by strong clinical evidence and guideline inclusion.